Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer.

"availability of data and materials the rna-seq data generated by this article are available in the ncbi sequence read archive repository with the following sra accession number: prjna882665 ( https://dataview ncbi nlm nih gov/object/prjna882665? availability of data and materials the rna-seq data generated by this article are available in the ncbi sequence read archive repository with the following sra accession number: prjna882665"

"Declarations Ethics approval and consent to participateThe experiments in the animal study were conducted using a protocol approved by the Animal Care and Use Committee of Shandong Cancer Hospital, the Shandong First Medical University (Jinan, China). Consent for publicationAll participating authors have read and approved this paper without any competing interests. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was funded by the National Natural Science Foundation of China (82030082, 82172676, and 82002719), the foundation of Natural Science Foundation of Shandong (ZR2021YQ52, ZR2020LZL016, and ZR2020QH240). Jinming Yu has received grants from the Academic Promotion Program of Shandong First Medical University (2019ZL002), the Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences (2019RU071). Dawei Chen has received grants from Young Elite Scientist Sponsorship Program By Cast, Grant/Award Number: No. YESS20210137. Fei Wu has received grants from the China Postdoctoral Science Foundation (2022M711977), the Clinical Medicine Innovation Program of Jinan City (202019125)."